Vanscoy Recognized for Building Smart Business(es)
Dr. Gordon Vanscoy, Chairman and CEO of PANTHERx Rare Pharmacy and RareMed Solutions, is honored to be headlining the April 2020 cover of Smart Business Magazine. The magazine features an …
Blog
Blog
PANTHERx Rare Delivers Uninterrupted Service Through Advanced Planning, Technology, and Associates who Truly Care
A lot has changed since PANTHERx released our first public statement nearly a month ago and we have been incredibly busy staying ahead of the curve. In Pennsylvania (home to …
PANTHERx Rare Patient Profile: Living with Primary Periodic Paralysis
At PANTHERx we often have the pleasure of getting to know not only our patients but also their families. Parents, children, and siblings can serve as caregivers and support to …
The Emergence and Reemergence of Specialty Pharmacy: JMCP Recounts a Father’s Prescient of the Specialty Pharmacy Industry and His Son’s Perspective 20 Years Later
This year, the highly respected Journal of Managed Care & Specialty Pharmacy (JMCP) celebrates its 25th anniversary. To mark this milestone, they are publishing a series of landmark articles documenting …
PANTHERx Closes 2019 with Another Consecutive #1 Patient Satisfaction Victory
PANTHERx Rare Pharmacy is proud to have again earned the #1 ranking in the quarterly patient satisfaction survey conducted by Zitter Health Insights, an independent national survey entity. For the …
PANTHERx: Prepared for Coronavirus (COVID-19)
The leadership at PANTHERx Rare has been closely monitoring the ongoing developments related to the concerns arising from the impact of Coronavirus (COVID-19). Nothing is more important to us than …
PANTHERx Chairman & CEO Featured on Podcast Highlighting Entrepreneurial Business Leaders
PANTHERx Rare Chairman & CEO, Dr. Gordon Vanscoy, shares his experiences identifying opportunities, building businesses, and advancing the rare pharmacy industry on the podcast Going Deep with Aaron Watson. Listen …
PANTHERx® Rare Pharmacy Selected by Blueprint Medicines Corporation to Distribute AYVAKIT™ (avapritinib) for Genomically Defined Patient Population with Rare Cancer, GIST
Read the Official PANTHERx Press Release. PANTHERx® Rare Pharmacy announces that it has been selected by Blueprint Medicines Corporation as a very limited distribution partner for breakthrough drug AYVAKIT™ (avapritinib). …
Consistent Rise in Orphan Drug Approvals Brings Doses of Hope to the Rare Disease Community
The end of the decade brought with it an exciting and critical trend for people living with rare diseases. Over the last eight years, the Center for Drug Evaluation and …
PANTHERx® Rare Pharmacy Selected by Harmony Biosciences to Distribute WAKIX® (pitolisant)
PANTHERx® Rare Pharmacy announces that it has been selected by Harmony Biosciences, LLC (Harmony) to distribute WAKIX® (pitolisant). PANTHERx is one of a select few specialty pharmacies providing nationwide access …